The microbiome: A new frontier in cancer immunotherapy - From mechanistic insights to clinical translation
International Journal of Molecular and Immuno Oncology · 05.08.2026 · 11 · 68-71
DOI: 10.25259/ijmio_17_2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular and Immuno Oncology, online erschienen am 05.08.2026. Verfasst von Akhil Kapoor und 1 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
International Journal of Molecular and Immuno Oncology (IJMIO) is a peer-reviewed journal where clinicians and researchers can contribute and keep up with the fast-paced developments in Molecular Biology and Immuno oncology.
Zitieren
APA
Kapoor, A., & Rungta, A. (2026). The microbiome: A new frontier in cancer immunotherapy - From mechanistic insights to clinical translation. International Journal of Molecular and Immuno Oncology, 11, 68-71. https://doi.org/10.25259/ijmio_17_2026
Vancouver
Kapoor A, Rungta A. The microbiome: A new frontier in cancer immunotherapy - From mechanistic insights to clinical translation. International Journal of Molecular and Immuno Oncology. 2026;11:68-71. doi:10.25259/ijmio_17_2026
BibTeX
@article{Kapoor2026,
author = {Kapoor, Akhil and Rungta, Archi},
title = {The microbiome: A new frontier in cancer immunotherapy - From mechanistic insights to clinical translation},
journal = {International Journal of Molecular and Immuno Oncology},
year = {2026},
volume = {11},
pages = {68--71},
doi = {10.25259/ijmio_17_2026}
}
EUVIMED